Benzinga's Top #PreMarket Gainers
Conatus Pharmaceuticals (NASDAQ: CNAT) shares gained 25.57% to $7.71 in the pre-market as the company confirmed the FDA Orphan Drug Designation for emricasan for treatment of liver transplant recipients with reestablished fibrosis.
Tesla Motors (NASDAQ: TSLA) shares jumped 5.92% to $131.52 in pre-market trading after the company announced that the German regulator has closed review of Model S incidents. Morgan Stanley named the stock a Top Pick in the auto sector.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.